![]() |
Volumn 166, Issue 1, 2012, Pages 232-
|
Association of systemic psoriasis therapies and incidence of myocardial infarction
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADALIMUMAB;
ALEFACEPT;
C REACTIVE PROTEIN;
CYCLOSPORIN A;
EFALIZUMAB;
ETANERCEPT;
INFLIXIMAB;
METHOTREXATE;
PSORALEN;
TUMOR NECROSIS FACTOR ALPHA INHIBITOR;
CARDIOVASCULAR RISK;
DISEASE ASSOCIATION;
DISEASE CLASSIFICATION;
DRUG EFFECT;
ELECTRONIC MEDICAL RECORD;
HEART INFARCTION;
HUMAN;
INCIDENCE;
LETTER;
PHOTOTHERAPY;
PREDICTIVE VALUE;
PRIORITY JOURNAL;
PSORIASIS;
PUVA;
ANTI-INFLAMMATORY AGENTS;
FEMALE;
HUMANS;
MALE;
MYOCARDIAL INFARCTION;
PSORIASIS;
|
EID: 84555202355
PISSN: 00070963
EISSN: 13652133
Source Type: Journal
DOI: 10.1111/j.1365-2133.2011.10666.x Document Type: Letter |
Times cited : (4)
|
References (7)
|